✦ LIBER ✦

In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465

✍ Scribed by Joseph M. Negri; Douglas W. McMillin; Jake Delmore; Nicholas Mitsiades; Patrick Hayden; Steffen Klippel; Teru Hideshima; Dharminder Chauhan; Nikhil C. Munshi; Carolyn A. Buser; John Pollard; Paul G. Richardson; Kenneth C. Anderson; Constantine S. Mitsiades

Book ID: 108676493
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 351 KB
Volume: 147
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.07891.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro anti-leukaemia activity of sphi

In vitro anti-leukaemia activity of sphingosine kinase inhibitor

✍ Clara Ricci; Francesco Onida; Federica Servida; Franca Radaelli; Giorgia Saporit 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB

Activity of a novel Aurora kinase inhibi

Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL: In vitro and in vivo studies

✍ Daigo Akahane; Tetsuzo Tauchi; Seiichi Okabe; Kousuke Nunoda; Kazuma Ohyashiki 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB

Blockade of the MEK/ERK signalling casca

Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo

✍ Kihyun Kim; Sun-Young Kong; Mariateresa Fulciniti; Xianfeng Li; Weihua Song; Sab 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Anti-neoplastic effect of protein kinase

Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro

✍ Hanna Lawnicka; Magdalena Kowalewicz-Kulbat; Paulina Sicinska; Zygmunt Kazimierc 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 289 KB

Activation of Src kinase by protein–tyro

Activation of Src kinase by protein–tyrosine phosphatase–PEST in osteoclasts: Comparative analysis of the effects of bisphosphonate and protein–tyrosine phosphatase inhibitor on Src activation in vitro

✍ Meenakshi A. Chellaiah; Michael D. Schaller 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

## Abstract PTP–PEST is involved in the regulation of sealing ring formation in osteoclasts. In this article, we have shown a regulatory role for PTP–PEST on dephosphorylation of c‐Src at Y527 and phosphorylation at Y418 in the catalytic site. Activation of Src in osteoclasts by over‐expression of

Antitumor activity of the selective epid

Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa® (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo

✍ Ichiro Naruse; Tohru Ohmori; Yoko Ao; Hisao Fukumoto; Toshio Kuroki; Masatomo Mo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB 👁 1 views

## Abstract Selective tyrosine kinase inhibitors are regarded as promising antitumor agents for cancer treatment. Iressa® (ZD1839) is an orally active, selective EGFR‐TKI (epidermal growth factor receptor‐tyrosine kinase inhibitor) that blocks signal transduction pathways implicated in cancer cell